Related references
Note: Only part of the references are listed.Histologic Remission: The Ultimate Therapeutic Goal in Ulcerative Colitis?
Laurent Peyrin-Biroulet et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2014)
Histologic Evaluation of Ulcerative Colitis: A Systematic Review of Disease Activity Indices
Mahmoud H. Mosli et al.
INFLAMMATORY BOWEL DISEASES (2014)
Multilayered epithelium at the gastroesophageal junction is a marker of gastroesophageal reflux disease: data from a prospective Central European multicenter study (histoGERD trial)
Cord Langner et al.
VIRCHOWS ARCHIV (2014)
Microscopic Features for Initial Diagnosis and Disease Activity Evaluation in Inflammatory Bowel Disease
Aude Bressenot et al.
INFLAMMATORY BOWEL DISEASES (2013)
Correlation Between the Endoscopic and Histologic Score in Assessing the Activity of Ulcerative Colitis
Bart Lemmens et al.
INFLAMMATORY BOWEL DISEASES (2013)
European consensus on the histopathology of inflammatory bowel disease
F. Magro et al.
JOURNAL OF CROHNS & COLITIS (2013)
Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing
Talat Bessissow et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2012)
Review article: defining remission in ulcerative colitis
S. P. L. Travis et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2011)
Mucosal Healing as an Index of Colitis Activity: Back to Histological Healing for Future Indices
Burton I. Korelitz
INFLAMMATORY BOWEL DISEASES (2010)
New pathophysiological insights and modern treatment of IBD
Matthias A. Engel et al.
JOURNAL OF GASTROENTEROLOGY (2010)
Therapeutic Strategies for the Management of Ulcerative Colitis
Siew C. Ng et al.
INFLAMMATORY BOWEL DISEASES (2009)
MECHANISMS OF DISEASE Inflammatory Bowel Disease
Clara Abraham et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
Roopali Bansal Gupta et al.
GASTROENTEROLOGY (2007)
Unravelling the pathogenesis of inflammatory bowel disease
R. J. Xavier et al.
NATURE (2007)
Inflammatory bowel disease diagnosis, evaluation and classification: state-of-the art approach
Stephan R. Targan et al.
CURRENT OPINION IN GASTROENTEROLOGY (2007)
Outcome measurement in clinical trials for Ulcerative Colitis: towards standardisation
Rachel M. Cooney et al.
TRIALS (2007)
A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis
Geert D'Haens et al.
GASTROENTEROLOGY (2007)
Comparison of the efficacy and safety of Eudragit-L-coated mesalazine tablets with ethylcellulose-coated mesalazine tablets in patients with mild to moderately active ulcerative colitis
PR Gibson et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)
European evidence based consensus on the diagnosis and management of Crohn's disease:: definitions and diagnosis
EF Stange et al.
GUT (2006)
Safety of celecoxib in patients with ulcerative colitis in remission: A randomized, placebo-controlled, pilot study
WJ Sandborn et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2006)
Treatment of ulcerative colitis with a humanized antibody to the α4β7 integrin
BG Feagan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
The Optimal Dose of 5-Aminosalicylic Acid in Active Ulcerative Colitis: A Dose-Finding Study With Newly Developed Mesalamine
Wolfgang Kruis et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2003)
A reproducible grading scale for histological assessment of inflammation in ulcerative colitis
K Geboes et al.
GUT (2000)
Share Paper
